Summer 2012 Clinical Trials

Over 450 clinical trials, including national trials, are currently underway at Cooper University Hospital, addressing a wide-range of novel pharmacologic, surgical and device related therapeutic options. Cooper’s robust research program offers...

posted on: Jun 27, 2012

Surgeons at Cooper Neurological Institute Using Cutting-Edge Technology

The Cooper Neurological Institute (CNI), which offers the only pituitary and neuroendocrine program in South Jersey, remains at the forefront of minimally invasive neuroendoscopy for pituitary tumors and other brain disorders with the recent...

posted on: Jan 18, 2012

Cooper Embarks on Ground-Breaking Trial of First, Totally Subcutaneous, Cardioverter-Defibrillator

It is estimated over 650,000 people in the United States currently have implanted cardiac devices (ICD’s) designed for defibrillation. Cooper University Hospital has recently become one of the first U.S. centers to participate in a ground-breaking...

posted on: Jan 10, 2011

Cooper National Coordinating Center for Novel Device to Treat Sepsis

Despite decades of advancements, severe sepsis remains the leading cause of death in intensive care units. More than 200,000 deaths are reported annually in the United States as a result of sepsis. The persistent high mortality of sepsis and septic...

posted on: Sep 30, 2010

Cooper leading global trial for endovascular treatment of Type B thoracic aortic dissection

Thoracic aortic dissection moved from the shadows to the spotlight after the sudden, untimely death of actor John Ritter. Although aortic dissection sends thousands of patients to the emergency room each year, Type B dissections are relatively rare...

posted on: Jun 8, 2010